Eledon Pharmaceuticals
ELDN----
Eledon Pharmaceuticals (ELDN)
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway t...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Eledon Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jun 23, 2026Price forecast
$9.00151.40%
Forecast & RatingStrong buy
6analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jul 21 at 06:58 AM
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
- PUBT · Jul 15 at 08:03 AM
NewcelX wins Brazil patent for NCEL-101 manufacturing process through 2036
- benzinga_article · Jul 10 at 04:05 PM
12 Health Care Stocks Moving In Friday's After-Market Session
- PUBT · Jul 8 at 08:15 AM
NewcelX appoints diabetes researcher Camillo Ricordi to scientific advisory board
- StockTitan · Jul 8 at 12:15 AM
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board | NCEL Stock News
- PUBT · Jul 2 at 01:32 PM
NewcelX reports successful FDA pre-IND meeting for NCEL-101 type 1 diabetes trial plan
